Treatment Outcomes and Survival Patterns of Asian Patients With Relapsed/Refractory Mantle Cell Lymphoma

BACKGROUND: Mantle cell lymphoma (MCL) is widely considered an incurable malignancy even with current therapies and relapsed/refractory (R/R) disease to primary treatment remains common. With improved treatment guidelines and the advent of novel agents, patients are increasingly being treated with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jing Yuan, Qiu, Tian Yu, Chiang, Jianbang, Tan, Ya Hwee, Yang, Valerie Shiwen, Chang, Esther Wei Yin, Poon, Eileen, Somasundaram, Nagavalli, Farid, Mohamad, Tao, Miriam, Lim, Soon Thye, Chan, Jason Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425802/
https://www.ncbi.nlm.nih.gov/pubmed/34527115
http://dx.doi.org/10.14740/jh890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425802/
https://www.ncbi.nlm.nih.gov/pubmed/34527115
http://dx.doi.org/10.14740/jh890

Ejemplares similares